TDC
CRBP icon

Thompson Davis & Co’s Corbus Pharmaceuticals CRBP Stock Holding History

Thompson Davis & Co’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$23K Buy
+102
New +$16.5K 0.05% 302

Other funds holding CRBP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Thompson Davis & Co's CRBP Position: Q3 2018 in Review

Thompson Davis & Co opened a new position in Corbus Pharmaceuticals (CRBP) in Q3 2018: 102 shares worth $23K. The stake represents 0.05% of the portfolio and ranks #302 among its holdings.

77 funds tracked by Wall St. Rank hold CRBP as of Q3 2018.

  • Thompson Davis & Co held 102 shares of Corbus Pharmaceuticals worth $23K as of Q3 2018.
  • Corbus Pharmaceuticals was a new Thompson Davis & Co position in Q3 2018.
  • Corbus Pharmaceuticals made up 0.05% of Thompson Davis & Co's portfolio in Q3 2018, its #302 holding.
  • 77 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.